It’s in the genes

It’s in the genes

A second Cambridge-based medical bioinformatics organisation has selected BizFlakes for a staff benefit management solution.


The first, Phoremost, produces a phenotypic screening platform which aims to identify new treatments for cancer and other diseases.  Its benefit scheme came into effect last month and saw take-up rates of over 90%.


Design of the Repositive benefit scheme began last month for benefits to come into effect by 1st October.